Items Tagged ‘General’

September 8th, 2017

CancerConnect On Line Support Community Available for Cancer Patients and Caregivers Impacted by Hurricane Irma

By

CancerConnect is a specialized social network for patients with cancer and their caregivers. All the members of the CancerConnect community are hoping for the best for everyone in Florida facing the coming wrath of Hurricane Irma. We are especially concerned for post surgical individuals and those undergoing chemotherapy and want to available for anyone with […]

View full entry

Tags: Cancer Patient Support, Cancer Patients, CancerConnect, Florida, Florida Cancer Centers, Florida Cancer Clinics, Florida Cancer Hospitals, General, Hurricane Irma, News


September 7th, 2017

Liquid Biopsies Find Distinct Genomic Profiles in Most Patients with Carcinoma of Unknown Primary

By

New research suggests that a simple blood test to evaluate circulating tumor DNA (ctDNA) can correctly identify distinct genomic profiles with potentially treatable targetable alterations in patients with carcinoma of unknown primary (CUP).1 Identifying the origin of cancers historically referred to as a cancer of unknown primary it has been problematic to determine how to […]

View full entry

Tags: Carcinoma of Unknown Primary, circulating tumor DNA, General, Genomic Profile, Liquid Biopsy, News, Precision Cancer Medicine


July 19th, 2017

New Study Suggests Most Cancers are Unavoidable Irrespective of Life Style

By

Two thirds of cancers are unavoidable even if you live a healthy life, according to a study published by doctors from John Hopkins.  The research, published in the journal Science, indicates that the majority of cancer-causing mutations are due to DNA copying errors. The recent discovery challenges the widespread belief that cancer mutations are generally inherited or triggered […]

View full entry

Tags: All Cancer Types, General, genetic risk of cancer, News, Other News Topics (not Types of Cancer), Precision Cancer Medicine


April 21st, 2017

Immunotherapy for Glioblastoma Well Tolerated; Survival Gains Observed

By

Small, phase one trial of a dendritic cell vaccine supports further study in larger trials A phase one study of 11 patients with glioblastoma who received injections of an investigational vaccine therapy and an approved chemotherapy showed the combination to be well tolerated while also resulting in unexpectedly significant survival increases, researchers at the Duke […]

View full entry

Tags: General, glioblastoma, immunotherapy, News, Other News Topics (not Types of Cancer)


March 31st, 2017

FDA Approves Bavencio as First Treatment for Merkel Cell Cancer

By

The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior chemotherapy. This is the first FDA-approved treatment for metastatic MCC. According to the National Cancer Institute, approximately […]

View full entry

Tags: Bavencio, General, Merkel Cell Cancer, News, PD-1, Skin Cancer


March 23rd, 2017

SWOG Launches National Immunotherapy Clinical Trial for Rare Cancers

By

People with rare cancers now have the option of joining a national clinical trial testing leading-edge immunotherapies for a wide variety of tumor types. It’s the first federally funded immunotherapy trial devoted to rare cancers. Despite their name, rare cancers make up more than 20 percent of cancers diagnosed worldwide. The trial is called DART, […]

View full entry

Tags: All Cancer Types, General, immunotherapy, keytruda, Neuroblastoma, News, Other News Topics (not Types of Cancer), Retinoblastoma, Sarcoma, Vaginal Cancer


March 17th, 2017

Dealing with Distress

By

Why it’s important to acknowledge distress during cancer care and what to do about it By Teresa L. Deshields and Clorinda Walley The moment a patient is diagnosed with cancer, one symptom is likely to surface: distress. Sadness, fear, helplessness, anger, social concerns, depression, anxiety, panic – just about everyone that has cancer suffers distress […]

View full entry

Tags: General, general cancer, News


March 1st, 2017

Xermelo-new option for controlling symptoms of Carcinoid Syndrome

By

The US Food and Drug Administration (FDA) today approved the oral therapy Xermelo (telotristat ethyl) to be used in combination with somatostatin analog (SSA) therapy for the treatment of adults with carcinoid syndrome diarrhea. Carcinoid syndrome is a cluster of symptoms that occurs in patients with advanced neuroendocrine tumors (NET) and the related diarrhea results […]

View full entry

Tags: carcinoid syndrome, General, NET, neuroendocrine tumors, News, Other News Topics (not Types of Cancer), Xermelo


February 23rd, 2017

Cancer Connect Launches On line Community for Patients with Neuroendocrine Tumors

By

Sun Valley ID & Austin TX— OMNI Health Media (OMNI) announces the launch of a new online community on CancerConnect for individuals with neuroendocrine tumors (NET). This community will provide patients and their loved ones with information and support. Join the conversation in the NET community here. Although neuroendocrine tumors have historically been considered rare, […]

View full entry

Tags: General, neuroendocrine tumors, News, Other News Topics (not Types of Cancer)


October 7th, 2016

It’s in the Genes: Genetic Testing Tutorial

By

Advances in genetic testing are offering women more information than ever before about their genetic makeup and are providing opportunities for empowered decision making related to a wide range of health issues. In this recurring column, experts provide vital information about how genetic testing suits one’s individual needs, potential risks and benefits, and the role […]

View full entry

Tags: General, News, Other News Topics (not Types of Cancer)


July 19th, 2016

Loxo Oncology Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for LOXO-101

By

Loxo Oncology, Inc. (LOXO), a biopharmaceutical company innovating the development of highly selective medicines for patients with genetically defined cancers, announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to LOXO-101, a selective inhibitor of tropomyosin receptor kinase (TRK), “for the treatment of unresectable or metastatic solid tumors with NTRK-fusion […]

View full entry

Tags: All Cancer Types, Breakthrough Therapy Designation, FDA. BTD, General, LOXO-101, metastatic solid tumors, News, TRK fusions, unresectable


August 19th, 2015

Smoking Cessation Drug Not Boosting Number of Smokers Who Quit

By

The introduction of a new prescription smoking-cessation aid, varenicline, in 2006 has had no significant impact on the rate at which Americans age 18 and older successfully quit smoking, according to a study led by researchers at University of California, San Diego School of Medicine. The findings, published online August 17 in Tobacco Control, suggest […]

View full entry

Tags: cessation aides, Chantix, General, Other News Topics (not Types of Cancer), quit smoking, tobacco control, varenicline


August 12th, 2015

FDA Designates Breakthrough Therapy Designation for Azedra in Pheochromocytoma and Paraganglioma

By

The U.S. Food and Drug Administration (FDA) has designated Azedra as a Breakthrough Therapy for the treatment of patients with iobenguane-avid metastatic or recurrent pheochromocytoma and paraganglioma. Azedra is currently being evaluated in a pivotal Phase 2b trial, which is being conducted under a Special Protocol Assessment Agreement (SPA), and has received Orphan Drug and […]

View full entry

Tags: azedra, General, News, Other News Topics (not Types of Cancer), Paraganglioma, Pheochromocytoma


July 13th, 2015

theGIConnection and the Inflammatory Bowel Disease Support Foundation Partner to Provide Crohn’s Disease and Ulcerative Colitis Patients with Virtual Support Community

By

July 13, 2015 – Fort Worth TX/Sun Valley ID —OMNI Health Media (OMNI) and the Inflammatory Bowel Disease Support Foundation (IBDSF) are pleased to announce a partnership with TheGIConnection that will both improve access to and increase support of patients and their families impacted by a diagnosis of Crohn’s disease or ulcerative colitis, collectively known as […]

View full entry

Tags: Chron's disease, General, Inflammatory Bowel Disease Support Foundation, online community, Other News Topics (not Types of Cancer), theGIConnection, ulcerative colitis


November 10th, 2014

Tips for Cancer Caregivers: November is National Family Caregiver Month

By

Caring for a family member or friend with cancer is often very challenging. The experience can be exhausting both mentally and physically, but it actually becomes even more so when you don’t take care of yourself. I use a metaphor of a watering can and a garden to drive home this point. If your loved […]

View full entry

Tags: All Cancer Types, cancer caregiver, caregiver, caregiver support, General, News, Other News Topics (not Types of Cancer), support, Types of Cancer